drugset / Trial / NCT04814771

Mass Balance Study of TS-142 in Healthy Adult Subjects.

NCT04814771

Phase 1 Completed 6 enrolled Taisho Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

To assess the plasma pharmacokinetics, the routes extent of elimination, and the metabolites of TS-142 after single oral dose of \[14C\] TS-142 in Japanese healthy male subjects. To assess the safety of single oral dose of \[14C\] TS-142 in Japanese healthy male subjects.

Timeline

Start
2021-04-19
Primary completion
2021-05-19
Completion
2021-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject TS-142 Small molecule 7.5 mg Oral

Indications

No indication recorded.